Cargando…
Identification of the effect and mechanism of Yiyi Fuzi Baijiang powder against colorectal cancer using network pharmacology and experimental validation
Background: Yiyi Fuzi Baijiang powder (YFBP) is a traditional Chinese medicine used to treat colorectal cancer, although its bioactivity and mechanisms of action have not been studied in depth yet. The study intended to identify the potential targets and signaling pathways affected by YFBP during th...
Autores principales: | Xiang, Bin, Geng, Ruiman, Zhang, Zhengkun, Ji, Xuxu, Zou, Jiaqiong, Chen, Lihong, Liu, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637639/ https://www.ncbi.nlm.nih.gov/pubmed/36353478 http://dx.doi.org/10.3389/fphar.2022.929836 |
Ejemplares similares
-
Yiyi Fuzi Baijiang Decoction Alleviates Ulcerative Colitis Partly by Regulating TLR4-Mediated PI3K/Akt and NF-κB Pathways
por: Chen, Liping, et al.
Publicado: (2022) -
Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer
por: Xu, Yihua, et al.
Publicado: (2022) -
Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-κB/NLRP3 Inflammasome Signaling Pathway to Repair the Intestinal Epithelial Barrier, and Modulating Intestinal Microbiota
por: Yang, Jinguang, et al.
Publicado: (2023) -
Therapeutic effects of shaogan fuzi decoction in rheumatoid arthritis: Network pharmacology and experimental validation
por: Shi, Lu, et al.
Publicado: (2022) -
Exploring the mechanisms of neurotoxicity caused by fuzi using network pharmacology and molecular docking
por: An, Junsha, et al.
Publicado: (2022)